This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

---

---

Apixaban

ELIQUIS – BRISTOL-MYERS SQUIBB CANADA (NOC Search)

Patents:

• 2461202: , SUN PHARMA, APOTEX, ACCORD HEALTHCARE, PHARMASCIENCE, RIVA, JAMP, TEVA, SANDOZ
• 2791171: , SUN PHARMA, APOTEX, PHARMASCIENCE, ACCORD HEALTHCARE, RIVA, JAMP, TEVA, SANDOZ
• 3620880: JAMP

Unknown/Other

• PM(NOC) – T-132-20 – T-99-19

ACCORD HEALTHCARE

• PM(NOC) – T-80-20 – T-81-20

APOTEX

• Other – 19-A-17
• Appeal – A-178-19 (2019 FCA 194)
• PM(NOC) – T-350-18 – T-351-18 (2019 FC 1379)

JAMP

• PM(NOC) – T-1830-19 – T-214-22

PHARMASCIENCE

• Appeal – A-31-21 – A-32-21 (2022 FCA 142)
• PM(NOC) – T-97-19 (2023 FC 1023, 2021 FC 354) – T-98-19

RIVA

• PM(NOC) – T-1164-22 – T-1167-22

SANDOZ

• PM(NOC) – A-33-21 – A-34-21 – T-503-19 (2021 FC 1, 2020 FC 897) – T-504-19

SUN PHARMA

• PM(NOC) – T-373-21

TEVA

• PM(NOC) – T-1575-18

---

Return to the Patented Medicine Litigation page.